Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Caris Life Sciences

Tracked across 3 events · 111 articles · First seen May 29, 2026 · Last active Jul 09, 2026

Sentiment
-7
Attention
7
Events
3
Relationships
2
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
6 -80
Business
Impact: Caris Life Sciences is facing investigations by multiple law firms for alleged securities fraud due to lower-than-expected Q1 revenues and delayed FDA clearance for its TriNav Advance product, which caused a significant drop in its stock price.
Jun 02, 2026 · 31 articles
7 60
Tech
Impact: Caris Life Sciences' chief medical officer, George Sledge, provided expert commentary on the significance of Daraxonrasib's breakthrough in targeting the KRAS mutation.
May 29, 2026 · 74 articles
2 0
Business
Impact: Former employer of Sullivan; no direct impact from this event.
Jul 09, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Caris Life Sciences live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.